chr11-18347842-A-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005316.4(GTF2H1):c.976A>T(p.Asn326Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000941 in 1,605,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005316.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GTF2H1 | NM_005316.4 | c.976A>T | p.Asn326Tyr | missense_variant | 9/15 | ENST00000265963.9 | NP_005307.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GTF2H1 | ENST00000265963.9 | c.976A>T | p.Asn326Tyr | missense_variant | 9/15 | 1 | NM_005316.4 | ENSP00000265963.4 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000452 AC: 11AN: 243274Hom.: 0 AF XY: 0.0000531 AC XY: 7AN XY: 131786
GnomAD4 exome AF: 0.0000977 AC: 142AN: 1452764Hom.: 0 Cov.: 30 AF XY: 0.0000941 AC XY: 68AN XY: 722538
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 02, 2024 | The c.976A>T (p.N326Y) alteration is located in exon 10 (coding exon 8) of the GTF2H1 gene. This alteration results from a A to T substitution at nucleotide position 976, causing the asparagine (N) at amino acid position 326 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at